The FCA published revised guidance clarifying Consumer Duty obligations for wholesale firms, allowing those with non-UK business previously in scope to reassess their compliance frameworks. The MHRA published two separate guidance documents covering borderline product classification and the Innovation Accelerator programme for novel medical devices and life sciences products. The EBA published a roadmap setting out how it will deliver its mandates under the revised Deposit Guarantee Schemes Directive, signalling forthcoming obligations for EU-regulated deposit-takers.
For you: Wholesale firms with dual UK-EU operations should immediately review the FCA's revised Consumer Duty guidance to determine whether non-UK business lines can be removed from scope, then cross-reference any affected products against MHRA borderline classification guidance if those products also enter the UK market.
How to read this digest
▼
Enforcement
Fines, sanctions, rulings
Legislation
New laws, statutory instruments
Consultation
Calls for evidence
Guidance
Frameworks, codes of practice
↔ Divergence
UK-EU moving apart
Commentary
Background, no action needed
Click a domain tile to expand, then click a category tag to see individual items.
What matters today
Guidance
FCA guidance publication narrows Consumer Duty scope for wholesale firms
Updated scope clarification means wholesale firms may reduce Consumer Duty compliance overhead where non-UK business was previously treated as in-scope.
Financial Markets
Guidance
MHRA guidance publication clarifies borderline medical device classification rules
Correct pre-market classification is required before UK market entry, as misclassification triggers separate regulatory pathways with distinct conformity obligations.
Health & Life Sci
Enforcement
OPSS statutory guidance published on Cosmetic Products Enforcement Regulations 2013
Businesses placing cosmetic products on the UK market must review OPSS enforcement expectations set out in the statutory guidance to ensure ongoing compliance.
Product Safety
Legislation
EBA roadmap published for Deposit Guarantee Schemes Directive mandates
EU-regulated banks and deposit-takers must track EBA DGSD3 deliverables set out in the roadmap to anticipate and prepare for new deposit guarantee compliance obligations.
Life sciences and medtech companies developing novel products should assess eligibility for the MHRA Innovation Accelerator to access dedicated regulatory support pathways.
The European Commission consultation on draft trusted flagger guidelines under the Digital Services Act remains open after the deadline was extended to 10 July 2026.
The European Commission consultation on draft guidelines for classifying high-risk AI systems remains open after the deadline was extended to 23 July 2026.
Domains
AI Governance
2 items
2 consultation
Cybersecurity
1 item
1 consultation
Data Protection
1 item
1 commentary
Financial Markets
2 items
1 legislation1 commentary
Health & Life Sci
2 items
2 guidance
Product Safety
1 item
1 enforcement
AI Governance
The items categorised under AI Governance concern an EU call for proposals on safer and more inclusive social media platforms targeting youth-facing products, and a European Parliament opinion on extending CBAM scope to downstream goods. Neither item concerns AI governance regulation directly; compliance teams should monitor both for eligibility and scope implications.
Organisations developing youth-facing social media products or conducting DSA-adjacent research should assess eligibility and alignment with emerging EU platform safety standards.
Manufacturers and importers of downstream goods containing embedded carbon must track CBAM scope expansion to assess new disclosure and financial obligations.
Cybersecurity and Operational Resilience
The European Commission welcomed a political agreement on updated criminal law rules to combat child sexual abuse, with revised criminal definitions in the Directive carrying implications for organisations managing child safety obligations under EU law.
Organisations handling child safety obligations under EU law must track how updated criminal definitions in the Directive interact with existing DSA and CSAM detection duties.
Data Protection, Privacy and Surveillance
The EU announced a new €3 customs duty on low-value parcels, which compliance teams sourcing or selling low-value consumer goods into the EU must prepare for alongside associated customs and regulatory obligations.
Compliance teams sourcing or selling low-value consumer goods into the EU must prepare for new customs obligations and reinforced product safety checks from mid-2026.
Financial Markets, Conduct and Financial Crime
The FCA published revised guidance allowing wholesale firms to reassess and narrow their Consumer Duty compliance frameworks where non-UK business was previously included in scope. The EBA published a roadmap detailing how it will fulfil its mandates under the revised Deposit Guarantee Schemes Directive, signalling forthcoming obligations for EU-regulated banks and deposit-takers.
Wholesale firms can now reassess Consumer Duty compliance frameworks and reduce scope where non-UK business was previously captured, with direct cost and operational implications.
Health Data, Medical Devices and Life Sciences
The MHRA published guidance on borderline product classification to assist manufacturers and importers in correctly categorising products before UK market entry. Separately, the MHRA published guidance on its Innovation Accelerator programme, which offers regulatory support to life sciences and medtech companies developing novel products.
Manufacturers and importers must correctly classify borderline products before UK market entry, as misclassification triggers incorrect conformity pathways and enforcement risk.
Life sciences and medtech companies developing novel products should assess eligibility for MHRA Innovation Accelerator support to expedite UK regulatory engagement.
Product Safety, Conformity and Standards
The Office for Product Safety and Standards published statutory guidance on the Cosmetic Products Enforcement Regulations 2013, setting out enforcement expectations that businesses placing cosmetic products on the UK market must review.
Businesses placing cosmetic products on the UK market should review this guidance to understand OPSS enforcement expectations and compliance benchmarks.